Literature DB >> 1429828

p53 point mutations in primary human gastric carcinomas.

H Yokozaki1, H Kuniyasu, Y Kitadai, K Nishimura, H Todo, A Ayhan, W Yasui, H Ito, E Tahara.   

Abstract

p53 point mutations in primary gastric carcinomas were analyzed by performing cDNA deoxynucleotide sequencing of the gene. Out of 16, 9 (56.3%) primary gastric carcinoma cases, including early cancer, showed one or more p53 point mutations in their open-reading frame, and 4 out of 9 cases had a p53 point mutation within highly conserved domains. The characteristics of the p53 mutation spectrum observed in primary tumors were (a) frequent mutation at an A:T pair (50%, 7 out of 14 mutations), (b) high transversion incidence (29%, 4 out of 14 mutations), (c) no transition at CpG, and (d) no G:C to T:A transversion. Our results suggest that p53 mutation is a common event in gastric carcinoma occurring from the early stage of progression with its specific mutation spectrum.

Entities:  

Mesh:

Year:  1992        PMID: 1429828     DOI: 10.1007/bf01209657

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  AN EPIDEMIOLOGICAL INVESTIGATION OF GASTRIC CANCER.

Authors:  E L WYNDER; J KMET; N DUNGAL; M SEGI
Journal:  Cancer       Date:  1963-11       Impact factor: 6.860

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  T Sugimura; S Fujimura; T Baba
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

4.  Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

Authors:  J H Kim; T Takahashi; I Chiba; J G Park; M J Birrer; J K Roh; H De Lee; J P Kim; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  Histological effect of certain pickles on the human gastric mucosa. A preliminary report.

Authors:  W C MacDonald; F H Anderson; S Hashimoto
Journal:  Can Med Assoc J       Date:  1967-06-10       Impact factor: 8.262

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

9.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

10.  Kinetics of nitrosamide formation from alkylureas, N-alkylurethans, and alkylguanidines: possible implications for the etiology of human gastric cancer.

Authors:  S S Mirvish
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

View more
  26 in total

1.  Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.

Authors:  M Kobayashi; A Kawashima; M Mai; A Ooi
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers.

Authors:  T Hamamoto; H Yokozaki; S Semba; W Yasui; S Yunotani; K Miyazaki; E Tahara
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  p53 alteration in gastric precancerous lesions.

Authors:  Y H Shiao; M Rugge; P Correa; H P Lehmann; W D Scheer
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

4.  Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis.

Authors:  R Kushima; W Müller; M Stolte; F Borchard
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

5.  Prognostic significance of p53 protein expression in early gastric cancer.

Authors:  Andrea Rodrigues Gonçalves; Antonio Jose Vasconcellos Carneiro; Ivanir Martins; Paulo Antonio Silvestre de Faria; Maria Aparecida Ferreira; Eduardo Linhares Riello de Mello; Homero Soares Fogaça; Celeste Carvalho Siqueira Elia; Heitor Siffert Pereira de Souza
Journal:  Pathol Oncol Res       Date:  2010-11-30       Impact factor: 3.201

6.  Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.

Authors:  W Yasui; H Kuniyasu; H Yokozaki; S Semba; F Shimamoto; E Tahara
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 7.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

8.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

9.  The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers.

Authors:  M Hamada; T Fujiwara; A Hizuta; A Gochi; Y Naomoto; N Takakura; K Takahashi; J A Roth; N Tanaka; K Orita
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.